• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Med Virol . Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and

tetano

Editor, Senior Moderator
J Med Virol


. 2024 May;96(5):e29640.
doi: 10.1002/jmv.29640. Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China

Xin-Jing Zhao[SUP] 1 2 [/SUP], Xiao-Lin Liu[SUP] 3 [/SUP], Yu-Min Liang[SUP] 4 [/SUP], Sheng Zhang[SUP] 1 [/SUP], Ti Liu[SUP] 3 [/SUP], Li-Bo Li[SUP] 4 [/SUP], Wen-Guo Jiang[SUP] 4 [/SUP], Jin-Jin Chen[SUP] 1 [/SUP], Qiang Xu[SUP] 1 [/SUP], Chen-Long Lv[SUP] 1 [/SUP], Bao-Gui Jiang[SUP] 1 [/SUP], Zeng-Qiang Kou[SUP] 3 [/SUP], Guo-Lin Wang[SUP] 1 [/SUP], Li-Qun Fang[SUP] 1 2 [/SUP]



Affiliations
Abstract

After the termination of zero-COVID-19 policy, the populace in China has experienced both Omicron BA.5 and XBB waves. Considering the poor antibody responses and severe outcomes observed among the elderly following infection, we conducted a longitudinal investigation to examine the epidemiological characteristics and antibody kinetics among 107 boosted elderly participants following the Omicron BA.5 and XBB waves. We observed that 96 participants (89.7%) were infected with Omicron BA.5, while 59 (55.1%) participants were infected with Omicron XBB. Notably, 52 participants (48.6%) experienced dual infections of both Omicron BA.5 and XBB. The proportion of symptomatic cases appeared to decrease following the XBB wave (18.6%) compared to that after the BA.5 wave (59.3%). Omicron BA.5 breakthrough infection induced lower neutralizing antibody titers against XBB.1.5, BA.2.86, and JN.1, while reinfection with Omicron XBB broadened the antibody responses against all measured Omicron subvariants and may alleviate the wild type-vaccination induced immune imprinting. Boosted vaccination type and comorbidities were the significant factors associated with antibody responses. Updated vaccines based on emerging severe acute respiratory syndrome coronavirus 2 variants are needed to control the Coronavirus Disease 2019 pandemic in the elderly.

Keywords: Omicron BA.5 breakthrough infection; Omicron XBB reinfection; booster vaccination; elderly; neutralizing antibody.

 
Back
Top Bottom